Showing results (1-10 of 502) with videos related to
Sort By:
Pageof 51
Seminars in Arthritis and Rheumatism|October 2, 2013
Burden of disease in treated rheumatoid arthritis patients: going beyond the jointMaurizio Cutolo, George D Kitas, Piet L C M van RielRheumatology International|February 24, 2020
Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centersJulia M Weijers, Anne G Semb, Silvia Rollefstad, et al.Plos One|April 8, 2017
Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritisCynthia S Crowson, Silvia Rollefstad, George D Kitas, et al.Plos One|March 24, 2017
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritisCynthia S Crowson, Silvia Rollefstad, George D Kitas, et al.Arthritis Research & Therapy|October 7, 2005
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritisPiet L C M van Riel, Jaap FransenBest Practice & Research. Clinical Rheumatology|September 18, 2007
Established rheumatoid arthritis: clinical assessmentsPiet L C M van Riel, J FransenArthritis Research & Therapy|October 24, 2009
Outcome measures in inflammatory rheumatic diseasesJaap Fransen, Piet L C M van RielRheumatic Diseases Clinics of North America|December 8, 2009
The Disease Activity Score and the EULAR response criteriaJaap Fransen, Piet L C M van RielClinical and Experimental Rheumatology|October 21, 2016
The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritisPiet L C M van Riel, Lisanne RenskersBest Practice & Research. Clinical Rheumatology|May 5, 2004
Are better endpoints and better design of clinical trials needed?Jaap Fransen, Piet L C M van RielPageof 51